ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Oric Pharmaceuticals (NASDAQ:ORIC) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
Oric Pharmaceuticals (NASDAQ:ORIC) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Form SCHEDULE 13G Oric Pharmaceuticals, Filed by: BlackRock, Inc.
Form 4 Oric Pharmaceuticals, For: Jan 16 Filed by: Heyman Richard A.
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Form 4 Oric Pharmaceuticals, For: Jan 02 Filed by: You Angie
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.